Negative regulation of Toll-like receptor 4 signaling by the Toll-like receptor homolog RP105

被引:321
作者
Divanovic, S
Trompette, A
Atabani, SF
Madan, R
Golenbock, DT
Visintin, A
Finberg, RW
Tarakhovsky, A
Vogel, SN
Belkaid, Y
Kurt-Jones, EA
Karp, CL [1 ]
机构
[1] Cincinnati Childrens Hosp, Med Ctr, Div Mol Immunol, Cincinnati, OH 45229 USA
[2] Univ Cincinnati, Coll Med, Cincinnati, OH 45229 USA
[3] Univ Massachusetts, Sch Med, Dept Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA
[4] Rockefeller Univ, Lab Lymphocyte Signaling, New York, NY 10021 USA
[5] Univ Maryland, Dept Microbiol & Immunol, Baltimore, MD 21201 USA
[6] Univ Maryland, Dept Med, Baltimore, MD 21201 USA
关键词
D O I
10.1038/ni1198
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Activation of Toll-like receptor (TLR) signaling by microbial signatures is critical to the induction of immune responses. Such responses demand tight regulation. RP105 is a TLR homolog thought to be mostly B cell specific, lacking a signaling domain. We report here that RP105 expression was wide, directly mirroring that of TLR4 on antigen-presenting cells. Moreover, RP105 was a specific inhibitor of TLR4 signaling in HEK 293 cells, a function conferred by its extracellular domain. Notably, RP105 and its helper molecule, MD-1, interacted directly with the TLR4 signaling complex, inhibiting its ability to bind microbial ligand. Finally, RP105 regulated TLR4 signaling in dendritic cells as well as endotoxin responses in vivo. Thus, our results identify RP105 as a physiological negative regulator of TLR4 responses.
引用
收藏
页码:571 / 578
页数:8
相关论文
共 54 条
  • [1] Cutting edge: Cell surface expression and lipopolysaccharide signaling via the Toll-like receptor 4-MD-2 complex on mouse peritoneal macrophages
    Akashi, S
    Shimazu, R
    Ogata, H
    Nagai, Y
    Takeda, K
    Kimoto, M
    Miyake, K
    [J]. JOURNAL OF IMMUNOLOGY, 2000, 164 (07) : 3471 - 3475
  • [2] Inflammatory bowel disease: new insights into pathogenesis and treatment
    Ardizzone, S
    Porro, GB
    [J]. JOURNAL OF INTERNAL MEDICINE, 2002, 252 (06) : 475 - 496
  • [3] Natural measles causes prolonged suppression of interleukin-12 production
    Atabani, SF
    Byrnes, AA
    Jaye, A
    Kidd, IM
    Magnusen, AF
    Whittle, H
    Karp, CL
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2001, 184 (01) : 1 - 9
  • [4] CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity
    Belkaid, Y
    Piccirillo, CA
    Mendez, S
    Shevach, EM
    Sacks, DL
    [J]. NATURE, 2002, 420 (6915) : 502 - 507
  • [5] Innate immune sensing and its roots: the story of endotoxin
    Beutler, B
    Rietschel, ET
    [J]. NATURE REVIEWS IMMUNOLOGY, 2003, 3 (02) : 169 - 176
  • [6] Bingham CO, 2002, J RHEUMATOL, V29, P3
  • [7] ST2 is an inhibitor of interleukin 1 receptor and Toll-like receptor 4 signaling and maintains endotoxin tolerance
    Brint, EK
    Xu, DM
    Liu, HY
    Dunne, A
    McKenzie, ANJ
    O'Neill, LAJ
    Liew, FY
    [J]. NATURE IMMUNOLOGY, 2004, 5 (04) : 373 - 379
  • [8] Inhibition of interleukin 1 receptor/toll-like receptor signaling through the alternatively spliced, short form of MyD88 is due to its failure to recruit IRAK-4
    Burns, K
    Janssens, S
    Brissoni, B
    Olivos, N
    Beyaert, R
    Tschopp, J
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (02) : 263 - 268
  • [9] The molecular mechanism of B cell activation by toll-like receptor protein RP-105
    Chan, VWF
    Mecklenbräuker, I
    Su, IH
    Texido, G
    Leitges, M
    Carsetti, R
    Lowell, CA
    Rajewsky, K
    Miyake, K
    Tarakhovsky, A
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (01) : 93 - 101
  • [10] Triad3A, an E3 ubiquitin-protein ligase regulating Toll-like receptors
    Chuang, TH
    Ulevitch, RJ
    [J]. NATURE IMMUNOLOGY, 2004, 5 (05) : 495 - 502